Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women

BJU International
Roberta E BlandonChristopher J Klingele

Abstract

To describe the development of screening tests and to identify re-operation rates after the permanent implant phase, and its characteristics, of the Interstim (Medtronic, Inc., Minneapolis, MI, USA) device for sacral nerve stimulation (SNS). We retrospectively reviewed the charts of women who had SNS between January 1998 and December 2005; their demographic, clinical and surgical information was abstracted. Descriptive statistics, chi-square and analysis of variance were used to compare the results. In all, 95 patients had 105 test procedures; 30 peripheral nerve evaluation (PNE) and 75 staged tined leads. Response rates were lower in the PNE than in the tined lead (40% vs 67%, P = 0.01). The indication for SNS was associated with the response rate, with urinary retention having the highest response (71%, P = 0.01). For the 55 implanted devices, there were 18 revisions (33%) and eight explants (15%). The main reasons for revision or explants were loss of efficacy (16/26) and pain at the implant site (six of 26). The median (range) time to intervention after implantation was 17 (1.2-75.0) months, and this was significantly associated with the indication. Revisions due to pain at the implant site were within the first year, and r...Continue Reading

References

Jan 1, 1979·Urologia Internationalis·R A Schmidt, E A Tanagho
Dec 1, 1988·The Journal of Urology·E A Tanagho, R A Schmidt
May 1, 1997·British Journal of Urology·K EveraertW Oosterlinck
Oct 12, 2000·European Urology·M J SwinnC J Fowler
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Oct 29, 2002·Current Opinion in Obstetrics & Gynecology·Paul D M PettitAnita H Chen
Oct 8, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·Kenneth M PetersDavid B Konstandt
Nov 18, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·Kristene E WhitmoreJames Chivian Lukban
Feb 10, 2004·The Journal of Urology·Ranan DasGupta, Clare J Fowler
Aug 5, 2004·BJU International·Ranan DasguptaClare J Fowler
Jul 1, 2005·World Journal of Urology·Michele SpinelliJohn Heesakkers
May 16, 2006·The Journal of Urology·Brian L CohenAngelo Gousse
May 16, 2006·The Journal of Urology·Donna Y DengLarissa V Rodríguez
Nov 2, 2006·Neurourology and Urodynamics·Suzette E SutherlandSteven W Siegel

❮ Previous
Next ❯

Citations

Oct 26, 2010·International Urogynecology Journal·Paul Pettit
May 17, 2012·International Urogynecology Journal·Christopher P ChungErin T Bird
Aug 8, 2012·Current Urology Reports·Maude E CarmelHoward B Goldman
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Yahya Q GhazwaniMagdy Hassouna
Aug 2, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Daniel Liberman, Luc Valiquette
Jul 3, 2013·Annals of Surgery·Yasuko MaedaSøren Laurberg
Aug 22, 2014·Current Opinion in Urology·Niels V JohnsenRoger R Dmochowski
May 19, 2009·Current Opinion in Urology·John F Bolton, Simon C W Harrison
Apr 25, 2013·Female Pelvic Medicine & Reconstructive Surgery·Cheryl ShihClaire C Yang
Jan 15, 2013·The Journal of Urology·Andrew T LenisRaymond R Rackley
Dec 8, 2010·The British Journal of Surgery·Y MaedaS Laurberg
Apr 27, 2010·Neurourology and Urodynamics·Nazema Y SiddiquiCindy L Amundsen
Jun 6, 2013·Neurourology and Urodynamics·Stephanie A JacobsKaren L Noblett
Dec 4, 2015·Neurourology and Urodynamics·Lisette A T HoenBertil F M Blok
May 10, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Klaus Bielefeldt
Dec 12, 2018·Arab Journal of Urology·Issam S Al-Azzawi, Mohamed A J Al-Tamimi
Jul 3, 2013·Nature Reviews. Urology·Jamie BartleyKenneth Peters
Nov 21, 2015·Neurourology and Urodynamics·Kenneth M PetersJudith A Boura
Nov 8, 2019·Neuromodulation : Journal of the International Neuromodulation Society·Matthew M GevelingerPaula J Doyle
Nov 19, 2020·Neurourology and Urodynamics·Neil J KocherHoward B Goldman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.